576 related articles for article (PubMed ID: 8045132)
1. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
Dorflinger LJ
Contraception; 1994 May; 49(5):455-68. PubMed ID: 8045132
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
3. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
4. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Koetsawang S
Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
[TBL] [Abstract][Full Text] [Related]
5. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
[TBL] [Abstract][Full Text] [Related]
6. Existing once-a-month combined injectable contraceptives.
Toppozada MK
Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
[TBL] [Abstract][Full Text] [Related]
7. A review of "once-a-month" combined injectable contraceptives.
Newton JR; D'arcangues C; Hall PE
J Obstet Gynaecol (Lahore); 1994; 4 Suppl 1():S1-34. PubMed ID: 12290848
[TBL] [Abstract][Full Text] [Related]
8. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of once-a-month injectable contraceptives.
Garza-Flores J
Contraception; 1994 Apr; 49(4):347-59. PubMed ID: 8013219
[TBL] [Abstract][Full Text] [Related]
10. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
Seibert B; Günzel P
Contraception; 1994 Apr; 49(4):303-33. PubMed ID: 8013217
[TBL] [Abstract][Full Text] [Related]
11. [Hormonal contraception].
Van Cauwenberge JR
Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of oral contraceptive use.
Williams RS
Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Hassan EO; el-Nahal N; el-Hussein M
Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
[TBL] [Abstract][Full Text] [Related]
14. [The choice of oral contraception in 1984: general indications and specific cases].
Gaspard U
Rev Med Liege; 1984 Apr; 39(7):261-5. PubMed ID: 6729293
[TBL] [Abstract][Full Text] [Related]
15. Prescription contraceptives: countering the risks.
Ruggiero RJ
Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
[TBL] [Abstract][Full Text] [Related]
16. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary complications of oral contraceptives.
Lindberg MC
J Gen Intern Med; 1992; 7(2):199-209. PubMed ID: 1336797
[TBL] [Abstract][Full Text] [Related]
18. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
19. Long-acting steroids provide new options.
Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
[TBL] [Abstract][Full Text] [Related]
20. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives.
Bassol S; Garza-Flores J
Contraception; 1994 May; 49(5):441-53. PubMed ID: 8045131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
